Setting the benchmark for tailoring treatment with EGFR tyrosine kinase inhibitors

  1. Rosell, R.
  2. Taron, M.
  3. Sanchez, J.J.
  4. Paz-Ares, L.
Aldizkaria:
Future Oncology

ISSN: 1479-6694 1744-8301

Argitalpen urtea: 2007

Alea: 3

Zenbakia: 3

Orrialdeak: 277-283

Mota: Artikulua

DOI: 10.2217/14796694.3.3.277 GOOGLE SCHOLAR